Skip to main content

A research study of a possible new treatment for PTSD

The ACM-001 study is testing whether one dose of an investigational medicine, given with support from trained therapists, can help adults living with post-traumatic stress disorder (PTSD).

Check if you can take part

Takes about 1 minute

A person sitting on a grassy ridge, looking out over hazy mountain ridges at sunset
Photo by Thierry Lemaitre on Unsplash

About the study

ACM-001 is an investigational medicine, which means it's still being tested and isn't approved for use outside research. It's a lab-made form of psilocybin, a substance found in some mushrooms.

  • One dose, with support

    You take ACM-001 once, during a day at the clinic with 2 trained therapists beside you.

  • 3 dose strengths

    People are put into 1 of 3 groups by chance, each with a different strength. You and the study team won't know which you had.

  • Care throughout

    A study team checks on your health and wellbeing at every stage, from your first visit to your last.

About PTSD

Post-traumatic stress disorder can develop after someone goes through, or sees, something frightening or distressing.

People with PTSD may relive what happened through flashbacks or nightmares, avoid things that remind them of it, and feel on edge or low for a long time afterwards.

Talking therapies and medicines help many people, but they don't work for everyone. Research studies like this one look for new ways to help.

What taking part involves

Taking part lasts about 4 months, from your first visit to your last.

Time in the study: About 4 months

  1. Screening and preparation

    2 to 6 weeks

    You visit the clinic for checks, including interviews, a heart trace and blood tests. If you take antidepressants or antipsychotics, the study doctor helps you stop them safely, and you stay off them for at least 2 weeks before your dose, or longer for a few medicines. You also meet your therapist to prepare.

  2. The day before your dose

    1 day

    You have a final preparation session with your therapist and answer questions about your symptoms.

  3. Dosing day

    1 day

    You take ACM-001 at the clinic, with 2 therapists supporting you for about 6 to 8 hours. Someone then takes you home.

  4. The day after

    1 day

    You talk through your experience with your therapist and have a safety check.

  5. Follow-up

    12 weeks

    You visit the clinic 4 more times and have 2 phone calls, so the study team can see how you're doing.

Who can take part

You may be able to take part if you:

  • are 18 or older

  • have PTSD from something that happened when you were an adult

  • can visit the clinic regularly for about 4 months

  • can name someone the study team can contact in an emergency

You can't take part if you:

  • have had psychosis, schizophrenia, bipolar disorder, obsessive compulsive disorder or a personality disorder

  • have had depression as your main diagnosis in the last 6 months

  • have taken a psychedelic, such as psilocybin, MDMA or LSD, in the last year

  • are pregnant, breastfeeding or planning a pregnancy

  • have had a stroke or heart attack in the last year, or have high blood pressure or a heart rhythm problem

The study team checks everything at your first visit. This list doesn't include every reason someone can't take part.

Questions

If your question isn’t here, the study team can answer it at your first visit.

A research study tests whether a new treatment works and is safe. It's how new treatments are found and approved.

Not necessarily. People are put into 1 of 3 groups by chance, and each group has a different strength. Comparing the groups shows whether the dose makes a difference. You won't know which group you're in.

ACM-001 is still being tested, which is why the study team watches your health closely. It can cause side effects such as headaches, feeling sick and changes in how you see or feel things during the session. The study team will explain these before you agree to take part.

If you take antidepressants or antipsychotics, the study doctor will help you stop them during screening. You'll be off them for at least 2 weeks before your dose, or 4 weeks for a few longer-acting medicines. The study team checks all your medicines at your first visit.

No. The study treatment and visits are free, and your travel costs are paid.

Yes. You can stop at any time without giving a reason, and it won't affect your usual care.

Could this study be right for you?

Answer a few questions to find out if you might be able to take part.

Check if you can take part

Acme Therapeutics Ltd. Registered in England and Wales, company number 00000000. Registered office: 1 Demo Street, London, EC1A 1AA, United Kingdom.